Navigation Links
Genoptix Announces Participation at the 2010 UBS Global Life Sciences Conference
Date:9/13/2010

CARLSBAD, Calif., Sept. 13 /PRNewswire-FirstCall/ -- Genoptix, Inc. (Nasdaq: GXDX), a specialized laboratory services provider, today announced the Company's participation at the 2010 UBS Global Life Sciences Conference at the Grand Hyatt Hotel in New York City, to be held September 20-22, 2010.  

President and CEO Tina S. Nova, Ph.D., and Sam Riccitelli, EVP and COO of Genoptix, will present at the conference on Tuesday, September 21, 2010 beginning at noon EDT, when they will provide an overview of the Company's specialized diagnostic laboratory services business, growth strategies and financial performance.

The presentation is expected to last approximately 30 minutes and will be webcast live through the "Investors" section of the Genoptix website at www.genoptix.com. Those who would like to listen to the presentation should go to this site at least 15 minutes prior to the event to register, download and install any necessary software. An audio replay will be available for 30 days following the initial presentation webcast.

About Genoptix, Inc.

Genoptix is a leading specialized laboratory service provider focused on delivering personalized and comprehensive diagnostic services to its physician customers, community-based hematologists and oncologists. On the forefront of personalized diagnostic services, Genoptix's highly trained group of hematopathologists utilize sophisticated technology to provide integrated testing and actionable diagnostic reports.  Its diagnostic services are designed to optimize the care of patients suffering from hematomalignancies, or cancers of the blood and bone marrow, including leukemia and lymphoma, and other forms of cancer. Founded in 1999, Genoptix is a member of the Nasdaq Global Select Market, the S&P SmallCap 600 Index and the Russell 2000 Index and is headquartered in Carlsbad, California. For more information, please visit <
'/>"/>

SOURCE Genoptix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Genoptix, Inc. to Announce First Quarter 2010 Financial Results
2. Genoptix, Inc. to Announce Fourth Quarter and Full-Year 2009 Financial Results
3. Genoptix Announces Participation at Deutsche Bank 2009 MedTools Investor Conference
4. Genoptix Reports Continued Strong Growth for the Third Quarter and First Nine Months of 2009
5. Genoptix, Inc. Announces Availability of MPL W515 L/K Mutation Analysis for MPD at 49th Annual American Society of Hematology (ASH) Meeting
6. ERT Announces Upcoming Retirement of Michael McKelvey as Chief Executive Officer
7. Sysmex America Announces LabCorp Hematology Automation Agreement
8. K-V Pharmaceutical Company Announces Completion of U.S. Food and Drug Administration Inspection and Approval to Return its First Product to Market
9. Pharmacyclics Announces Date of Fiscal Year End 2010 Financial Results and Conference Call and Presentation at Stifel Nicolaus Healthcare Conference
10. Business & Decision North America Announces the Successful Go-Live of Microsoft Dynamics AX at DeVilbiss Healthcare
11. Misonix Announces New Distribution Agreement For Spain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... , Sept. 15, 2014  Valeant Pharmaceuticals International, ... that its wholly owned subsidiary, Valeant Pharmaceuticals International, will ... amount of its 6.75% Senior Notes due 2017, CUSIP ... 15, 2014 and has mailed an irrevocable notice of ... 2014, a copy of the irrevocable notice of redemption ...
(Date:9/15/2014)... DALLAS , Sept. 15, 2014 /PRNewswire-iReach/ -- MedicOne ... ambulance transport services, has been selected by Inc. ... companies in America. Photo - ... Inc. 500|5000 list identifies successful, privately-held companies with ... MedicOne Medical Response, one of only two ambulance ...
(Date:9/15/2014)...  Catalist-listed QT Vascular Ltd. ("QT Vascular" or together ... of minimally invasive medical devices for the treatment of ... has enrolled the first European patients in the ENDURE ... have already been enrolled in this study with Dr. ... Auckland, New Zealand . ...
Breaking Medicine Technology:Valeant Announces Redemption of All of the Outstanding $500.0 Million Aggregate Principal Amount of its 6.75% Senior Notes due 2017 2MedicOne Medical Response Named to 2014 Inc. 5000 Fastest Growing Companies List 2MedicOne Medical Response Named to 2014 Inc. 5000 Fastest Growing Companies List 3First European Patients Enrolled in QT Vascular's ENDURE Trial 2First European Patients Enrolled in QT Vascular's ENDURE Trial 3First European Patients Enrolled in QT Vascular's ENDURE Trial 4First European Patients Enrolled in QT Vascular's ENDURE Trial 5
(Date:9/15/2014)... Florida is now one of several states ... a breath test could be forced to undergo a mandatory ... will prevent more people from drinking and driving. , ... rate of breathalyzer refusal. The new law is aimed to ... CBS Miami , the new Florida law requires people to ...
(Date:9/15/2014)... 2014 (HealthDay News) -- Births of multiple babies cost ... than singleton births, researchers report. The researchers suggest ... fertilization (IVF) could ease some of that burden. ... in tandem with births to older mothers and use ... University of New South Wales, Australia. Their study, ...
(Date:9/15/2014)... New York (PRWEB) September 15, 2014 ... Market Research "Spectrometry Market - Global Industry Analysis, Size, ... global spectrometry market was valued at USD 12,212.9 million ... million by 2020 at a CAGR of 7.2% from ... employed to access properties of light within specific electromagnetic ...
(Date:9/15/2014)... (HealthDay News) -- Adding chest radiation to chemotherapy allows ... and cuts recurrence rates by nearly 50 percent, European ... four-country study, the researchers recommended that chest radiotherapy be ... who respond to chemotherapy. , , Small-cell lung cancer ... accounts for roughly 13 percent of all lung cancers. ...
(Date:9/15/2014)... freshmen understand the benefits of eating healthy foods and know ... lack confidence in their ability to act on that knowledge, ... new University of Illinois study. , "The women in our ... healthful diet, especially if they had to do something physical ... strong if they were at a party or in places ...
Breaking Medicine News(10 mins):Health News:New DUI Law Makes Blood Tests Mandatory 2Health News:Study Ties Multiple Births to Higher Costs, Complications 2Health News:Study Ties Multiple Births to Higher Costs, Complications 3Health News:Spectrometry Market Expected to Reach USD 19.6 Billion Globally in 2020: Transparency Market Research 2Health News:Spectrometry Market Expected to Reach USD 19.6 Billion Globally in 2020: Transparency Market Research 3Health News:Spectrometry Market Expected to Reach USD 19.6 Billion Globally in 2020: Transparency Market Research 4Health News:Spectrometry Market Expected to Reach USD 19.6 Billion Globally in 2020: Transparency Market Research 5Health News:Chest Radiation May Help Fight Some Advanced Lung Cancers: Study 2Health News:Chest Radiation May Help Fight Some Advanced Lung Cancers: Study 3Health News:Freshman girls know how to eat healthy but lack confidence in their ability to do it 2
... 30 A new poll by the Pew Research ... while most Catholics who have heard about the issue ... , deep divisions exist between the most-observant Catholics and ... are divided over their assessment of Obama,s job performance.Conducted ...
... YORK, April 30 ProMetic Life Sciences Inc. ... Corporation of America ("SCOA") announces that it has ... ("SPI"), both wholly owned subsidiaries of Sumitomo Corporation ("Sumitomo") ... to PBI-1402 for the Japanese market.In the course of ...
... 2 diabetes may have unintended effects on the pancreas that could ... a greater risk of pancreatic cancer in long-term users, UCLA researchers ... published in the online edition of the journal Diabetes , ... found that sitagliptin, sold in pill form as Januvia, caused abnormalities ...
... Immucor, Inc. (Nasdaq: BLUD ), a ... blood transfusion industry, today announced that access to its ... 2009 Health Care Conference in New York, NY will ... Company,s presentation is scheduled for Tuesday, May 12, 2009, ...
... and strategic focus to neurovascular interventions developer.PALO ALTO, Calif., ... today that its directors elected Eric P. Milledge as ... industry experience, business acumen and leadership to Nfocus, ... break-through technologies in the dynamic field of endovascular neurosurgery," ...
... The Alzheimer,s Association Minnesota-North Dakota in collaboration with the ... The Alzheimer,s Project on May 12 at 6:00 p.m. ... be followed by a question-and-answer panel of medical experts ... disease, The Alzheimer,s Project shows there is now genuine ...
Cached Medicine News:Health News:New Poll on Obama, Catholics and the Notre Dame Commencement Finds Deep Divisions Among Catholics 2Health News:Sumitomo to Act As Advisor to ProMetic for Japanese Market 2Health News:Sumitomo to Act As Advisor to ProMetic for Japanese Market 3Health News:Sumitomo to Act As Advisor to ProMetic for Japanese Market 4Health News:Popular diabetes treatment could trigger pancreatitis, pancreatic cancer 2Health News:Popular diabetes treatment could trigger pancreatitis, pancreatic cancer 3Health News:Nfocus Neuromedical Elects Eric P. Milledge Chairman of Board 2Health News:The Alzheimer's Project HBO Documentary Puts Spotlight On Alzheimer's Disease; Premiere Screening at the Hennepin County Library in Downtown Minneapolis 2
... is lightweight enough to shuttle easily between ... Designed with a goldmann standard 30 cm ... with 79 locations (including 30-2, 24-2, and ... different suprathresholds out to 30. Easyfield ...
... detections of any possible ... glaucoma in the visual ... Smooth operation of kinetic ... accuracy of static and ...
Focus Toric Monthly lenses. All the advantages of Focus Monthly lenses, now available for patients with astigmatism. Recommended for daily wear. Also approved for extended wear (1-7 days)....
Preference Toric quarterly planned replacement lenses are durable, easy to handle and virtually maintenance free. Meeting the needs of those suffering from astigmatism, these soft contact lenses are ...
Medicine Products: